Rigel Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
HENNER DENNIS director
Common Stock 2,030 N/A N/A
Sale
EVNIN LUKE other: Former 10% Owner
Common Stock 10,000 N/A N/A
Sale
MPM BIOVENTURES III QP LP other: Former 10% Owner
Common Stock 10,000 N/A N/A
Sale
SIMON NICHOLAS J III director
Common Stock 10,000 N/A N/A
Sale
HENNER DENNIS director
Common Stock 10,000 N/A N/A
Sale
EVNIN LUKE other: Former 10% Owner
Common Stock 3,950 N/A N/A
Sale
MPM BIOVENTURES III QP LP other: Former 10% Owner
Common Stock 3,950 N/A N/A
Sale
SIMON NICHOLAS J III director
Common Stock 3,950 N/A N/A
Sale
HENNER DENNIS director
Common Stock 3,950 N/A N/A
Sale
EVNIN LUKE other: Former 10% Owner
Common Stock 20,154 N/A N/A
Sale
MPM BIOVENTURES III QP LP other: Former 10% Owner
Common Stock 20,154 N/A N/A
Sale
SIMON NICHOLAS J III director
Common Stock 20,154 N/A N/A
Sale
HENNER DENNIS director
Common Stock 20,154 N/A N/A
Sale
EVNIN LUKE other: Former 10% Owner
Common Stock 5,861 N/A N/A
Sale
MPM BIOVENTURES III QP LP other: Former 10% Owner
Common Stock 5,861 N/A N/A
Sale
SIMON NICHOLAS J III director
Common Stock 5,861 N/A N/A
Sale
HENNER DENNIS director
Common Stock 5,861 N/A N/A
Sale
EVNIN LUKE other: Former 10% Owner
Common Stock 3,300 N/A N/A
Sale
MPM BIOVENTURES III QP LP other: Former 10% Owner
Common Stock 3,300 N/A N/A
Sale
SIMON NICHOLAS J III director
Common Stock 3,300 N/A N/A
Sale
HENNER DENNIS director
Common Stock 3,300 N/A N/A
Purchase
COOPER ROBIN D G officer: Sr. V.P. Pharmaceutica..
Common Stock 4,900 N/A N/A
Sale
EVNIN LUKE other: Former 10% Owner
Common Stock 139,313 N/A N/A
Sale
MPM BIOVENTURES III QP LP other: Former 10% Owner
Common Stock 139,313 N/A N/A
Sale
FRAZIER ALAN D director
Common Stock 2,333 N/A N/A
Sale
SIMON NICHOLAS J III director
Common Stock 139,313 N/A N/A
Sale
HENNER DENNIS director
Common Stock 139,313 N/A N/A
Sale
ALTA PARTNERS II INC other: X-ref Alta Partners II 5..
Common Stock 3,100 N/A N/A
Sale
DELEAGE JEAN director
Common Stock 3,100 N/A N/A
Sale
ALTA PARTNERS II INC other: X-ref Alta Partners II 5..
Common Stock 95,200 N/A N/A
Sale
DELEAGE JEAN director
Common Stock 95,200 N/A N/A
Sale
ALTA PARTNERS II INC other: X-ref Alta Partners II 5..
Common Stock 8,400 N/A N/A
Sale
DELEAGE JEAN director
Common Stock 8,400 N/A N/A
Sale
ALTA PARTNERS II INC other: X-ref Alta Partners II 5..
Common Stock 34,800 N/A N/A
Sale
DELEAGE JEAN director
Common Stock 34,800 N/A N/A
Sale
ALTA PARTNERS II INC other: X-ref Alta Partners II 5..
Common Stock 8,000 N/A N/A
Sale
DELEAGE JEAN director
Common Stock 8,000 N/A N/A
Sale
ALTA PARTNERS II INC other: X-ref Alta Partners II 5..
Common Stock 7,200 N/A N/A
Sale
DELEAGE JEAN director
Common Stock 7,200 N/A N/A
Sale
ALTA PARTNERS II INC other: X-ref Alta Partners II 5..
Common Stock 1,700 N/A N/A
Sale
DELEAGE JEAN director
Common Stock 1,700 N/A N/A
Sale
ALTA PARTNERS II INC other: X-ref Alta Partners II 5..
Common Stock 13,100 N/A N/A
Sale
DELEAGE JEAN director
Common Stock 13,100 N/A N/A
Sale
ALTA PARTNERS II INC other: X-ref Alta Partners II 5..
Common Stock 1,900 N/A N/A
Sale
DELEAGE JEAN director
Common Stock 1,900 N/A N/A
Sale
ALTA PARTNERS II INC other: X-ref Alta Partners II 5..
Common Stock 6,900 N/A N/A
Sale
EVNIN LUKE other: Former 10% Owner
Common Stock 133,698 N/A N/A
Sale
MPM BIOVENTURES III QP LP other: Former 10% Owner
Common Stock 133,698 N/A N/A
Sale
DELEAGE JEAN director
Common Stock 6,900 N/A N/A
Sale
SIMON NICHOLAS J III director
Common Stock 133,698 N/A N/A

Showing 150 to 200 of 237 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.